Company / Operating Cash Flow per Share
Rani Therapeutics Holdings, Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1246.52
FY2025
5-year range
-$2008.86 / -$0.77
FY2021-FY2025
Trend
+37.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-1246.52.
Based on SEC 10-K filings.
-1246.52 in FY2025.
Improved from $-1650.71 to $-1246.52 over the past 3 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 37.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1246.52 | +37.9% |
| FY2024 | -$2008.86 | -21.7% |
| FY2022 | -$1650.71 | -215441.4% |
| FY2021 | -$0.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026